Quinoxalinedione derivatives

Details for Australian Patent Application No. 2009259754 (hide)

Owner MERCK PATENT GMBH

Inventors Hallakou-Bozec, Sophie; Cravo, Daniel; Lepifre, Franck

Agent Griffith Hack

Pub. Number AU-A-2009259754

PCT Pub. Number WO2009/152909

Priority 08290564.7 16.06.08 EP

Filing date 19 May 2009

Wipo publication date 23 December 2009

International Classifications

C07D 241/44 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

3 February 2011 PCT application entered the National Phase

  PCT publication WO2009/152909 Priority application(s): WO2009/152909

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009259764-3-(3-pyrimidin-2-yl-benzyl)-[1,2,4]triazol o[4,3-b]pyridazine derivatives as Met kinase inhibitors

2009259740-Method for operating a Fischer-Tropsch synthesis